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Supernumerary marker chromosomes (SMCs) are common, but their molecular content andmechanism of origin are often not precisely
characterized.We analyzed all centromere regions to identify the junctionbetween theunique chromosome armand thepericentromeric
repeats. Amolecular-ruler clone panel for each chromosome armwas developed andused for the design of a customoligonucleotide array.
Of 27 nonsatellited SMCs analyzed by array comparative genomic hybridization (aCGH) and/or ﬂuorescence in situ hybridization (FISH),
seven (approximately 26%) were shown to be unique sequence negative. Of the 20 unique-sequence-positive SMCs, the average unique
DNA content was approximately 6.5 Mb (range 0.3–22.2 Mb) and 33 known genes (range 0–149). Of the 14 informative nonacrocentric
SMCs,ﬁve (approximately36%) containeduniqueDNAfromboth thepandqarms,whereasnine (approximately64%) containedunique
DNA fromonly one arm. The latter cases are consistent with ring-chromosome formation by centromeremisdivision, as ﬁrst described by
McClintock in maize. In one case, a r(4) containing approximately 4.4 Mb of unique DNA from 4p was also present in the proband’s
mother. However, FISH revealed a cryptic deletion in one chromosome 4 and reduced alpha satellite in the del(4) and r(4), indicating
that themotherwas a balanced ring anddeletioncarrier.Ourdata, and recent reports in the literature, suggest that this ‘‘McClintockmech-
anism’’ of small-ring formationmight be the predominantmechanismof origin. Comprehensive analysis of SMCs by aCGHand FISH can
distinguish unique-negative from unique-positive cases, determine the precise gene content, and provide information onmechanism of
origin, inheritance, and recurrence risk.Introduction
Supernumerary marker chromosomes (SMCs) are extra,
abnormal chromosomes whose origin cannot typically be
determined by conventional chromosome-banding tech-
niques. SMCs are common, occurring in four of every
10,000newborns, but are approximately 7 timesmoreprev-
alent in individuals with mental retardation.1 The most
common class ofmarker chromosomes are derived from ac-
rocentric chromosomes and have a satellited or bisatellited
structure, with chromosome 15 accounting for the highest
percentage of this group.2 Nonacrocentric-derived markers
are somewhat less common and are often suspected to be
small ring chromosomes on the basis of their morphologi-
cal appearance and behavior (including mitotic instability
leading to mosaicism).3
Certain marker chromosomes are large enough to be
identiﬁed byGbanding andhave awell-established pheno-
type and prognosis. Examples include iso(12p), associated
with Pallister-Killian syndrome4 (PKS [MIM 601803]), and
iso(18p), associated with mild-moderate mental retarda-
tion and a characteristic facial appearance.5 For chromo-
some 15-derived marker chromosomes, referred to as
inv dup(15), ﬂuorescence in situ hybridization (FISH) anal-
ysis allows discrimination between large markers contain-
ing SNRPN [MIM 182279] that are tetrasomic for the
Prader-Willi or Angelman Syndrome (PWS [MIM 176270]
or AS [MIM 105830]) critical region and small markers
that are negative for SNRPN. The former are associated
with mental retardation, seizures, autistic features, and398 The American Journal of Human Genetics 82, 398–410, Februagrowth retardation, whereas the latter are usually associ-
ated with a normal phenotype.6–8 FISH analysis of chromo-
some 22-derived markers can reveal whether the SMC con-
tains the critical region for Cat-Eye syndrome (CES [MIM
115470]), which is characterized by ocular coloboma and
other dysmorphic features.9
For the remainder of SMCs, empiric ﬁgures are used in a
prenatal setting for the prediction of the risk of a pheno-
typic abnormality. These data were compiled in a classic pa-
per published in this journal by D. Warburton in 199110
showing an overall risk for an abnormality for all marker
chromosomes of 13%. Subdividing marker chromosomes
into those containing satellites (derived from an acrocen-
tric chromosome) compared to nonsatellited chromo-
somes showed a lower empiric risk of abnormality among
satellited markers (11% versus 15%). Other studies have
demonstrated the risk of abnormality for SMCs derived
from nonacrocentrics to be is as high as 28%.11 Consistent
with this higher risk estimate, a recent study of 108 prena-
tally ascertained de novo SMCs found risks of 18% for
satellited markers and 31% for nonsatellited markers.12
The differences in risk estimates likely represent differences
in the inclusion criteria among these studies.
Clearly, more precise knowledge of the size of the partial
trisomy segment(s) and the gene content of the SMCwould
greatly improve our ability to predict phenotype and prog-
nosis. Many groups have utilized various FISH techniques
to identify a large number of marker chromosomes.13–22
Recently, Liehr and colleagues established a SMC cell-line
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characterization studies.23 These authors also have begun
to make genotype-phenotype correlations on approxi-
mately 400 cases of SMCs.3 Themajority of these cases con-
sisted of previously reported SMCs that were mapped with
a variety of FISH methods. Because most reports provided
only the chromosomal band for the delineation of the
breakpoints of the SMCs, precise determination of the
gene content within the SMC that might be contributing
to the phenotype is difﬁcult.
Current molecular cytogenetic technologies make it pos-
sible for us to identify the speciﬁc gene content of SMCs at
a high-resolution, and therefore to begin to deﬁne the
genotype-phenotype correlations associated with SMCs.
Over the past several years, array comparative genomic
hybridization (aCGH) has proven to be more sensitive in
the detection of small deletions and duplications as com-
pared to standard cytogenetic techniques, such as G band-
ing and FISH.24–27 In addition, a single aCGH study has the
capacity of generating information equivalent to many se-
quential or multiplex FISH assays, allowing for the rapid
identiﬁcation of unique DNA content. Recently, Shaffer
and colleagues28 utilized a microarray containing FISH-
mapped bacterial artiﬁcial chromosome (BAC) clones cov-
ering approximately 5 Mb adjacent to each centromere to
characterize SMCs. They fully characterized two-thirds of
the SMC cases by aCGH, whereas the remaining SMCs con-
tained euchromatic material that extended distal to the
5 Mb coverage on their array.28 These results demonstrate
the signiﬁcant variability of DNA content contained
within SMCs and emphasize the need for high-resolution
characterization of marker chromosomes.
In cases in which the morphology of the SMC can be
determined by cytogenetic analysis, almost 50% appear to
represent ring chromosomes.3 The mechanism by which
these small ring chromosomes form in humans is poorly
understood, but at least twomajormechanisms can be con-
sidered.29–31 In the ﬁrst, one break occurs in the p arm and
a secondbreak occurs in theq arm, and the twobroken ends
of the centric fragment fuse together to form a ring (Model
I). The resulting ring chromosome containsDNA fromboth
the p and q arms. A second mechanism involves a break
within the centromere, sometimes referred to as ‘‘centro-
mere misdivision,’’ along with a break in either the p or q
arm, forming a small ring chromosome (Model II).
Comprehensive analysis of SMCs with aCGH and FISH
analysis now has the capability to rapidly determine the
degree of partial trisomy (gene content) present, as well
as to provide information on the mechanism of formation
and inheritance critical for the determination of accurate
recurrence risks.
Material and Methods
BAC-Clone Selection and Validation
Previous efforts by the BAC Resource Consortium have placed
numerous BAC clones on the human genome sequence.32 ToThe Amenhance this dataset for the pericentromeric regions, our labora-
tory developed a molecular ruler clone panel for each of the 43
chromosome arms. A schematic of this design is shown in Figure 1.
The junction between the pericentromeric repeats and the unique
chromosome arm was identiﬁed, and BAC clones were selected
from this point to at least 5Mb distal on each arm. Cloneswere ini-
tially chosen from theNational Center for Biotechnology Informa-
tion (NCBI) Build 33 with the University of California, Santa Cruz
(UCSC) genome browser database, whereas subsequent clones
were chosen on the basis of the most current NCBI build.33–35
A contig of BAC clones were selected to cover the ﬁrst megabase
of DNA adjacent to the pericentromeric-unique DNA junction.
Extending from this contig, one BAC clone was placed every
500 kb up to at least 5 Mb into the p and q arms of each chromo-
some arm. Initial criteria for unique clone selection required the
clones to be fully sequenced and to contain less than 10% dupli-
cated sequence using the segmental duplication track.36 For each
chromosome arm, the most proximal, intermediate, and distal
FISH-validated clones meeting these criteria are listed in Table 1.
These clones contain less than 10% segmental duplications, and
their chromosomal localization was conﬁrmed by FISH analysis.
For cases in which a SMC was identiﬁed that contained unique
DNA greater than 5 Mb, additional clones were selected up to
15 Mb from the centromere gap. All FISH-tested clones (n ¼ 540)
are listed in Table S1 available online.
In addition to the clones within the unique chromosome arm,
clones were selected and analyzed within the pericentromeric re-
peat regions for each chromosome arm. These clones were utilized
in FISH analyses for the delineation of the pericentromere-unique
DNA junctions and for the characterization of SMCs that did not
contain unique DNA. By deﬁnition, clones in this region have
signiﬁcant repetitive DNA or segmental duplications; thus, all of
these clones contained more than 10% segmental duplications.
If sequenced clones were not available commercially, or if a clone
did not map correctly after two attempts, a corresponding clone
from the BAC end track or the Human 32K BAC Re-Array set was
chosen.
Bacterial stabs were obtained from The BACPAC Resource
Center (BPRC) at Children’s Hospital Oakland Research Institute
(Oakland, CA) or from Invitrogen (Carlsbad, CA) and streaked
onto Luria-Bertani (LB) plates with the appropriate antibiotic.
For each chromosome arm, at least four clones were mapped:
the most proximal unique clone, as well as the clones located
approximately 1, 3, and 5 Mb from the most proximal clone.
Any additional clones that were selected for SMC characterization
were also analyzed by FISH.
DNA was isolated from overnight cultures with the appropriate
antibiotic via an alkaline lysis procedure with an automated
extraction system (Autogen, Holliston, MA). For FISH assays,
ﬂuorescently labeled nucleotides (Spectrum Orange-dUTP, Spec-
trum Green-dUTP [Abbott Molecular, Des Plaines, IL] or Diethyla-
minocoumarin-5-dUTP [PerkinElmer Life Sciences, Boston, MA])
were incorporated into the clone DNA with a standard nick-
translation or random priming reaction. Slides were baked at
65C for proper aging, washed in 23 saline sodium citrate (SSC)
at 37C for 30 min, and hydrated sequentially in 70%, 80%, and
95% ice-cold ethanol. Chromosomes were denatured in 70%
formamide and 23 SSC at 73C for 55 s and then hydrated as be-
fore. Prior to hybridization, probes were denatured at 73C for 7
min and reannealed at 45C for 2 min. Chromosome spreads
were hybridized overnight at 37C. Slides were washed in 0.43
SSC and 0.3% NP-40 at 73C for 2 min, washed in 0.23 SSC anderican Journal of Human Genetics 82, 398–410, February 2008 399
Figure 1. Probe Design Strategy and
FISH Analysis for SMCs
(A) The black circle represents the large
array of alpha-satellite DNA comprising
each human centromere region. Because
these sequences are highly repeated and
difficult to sequence, they appear as the
centromere gaps on physical maps of the
genome. Adjacent to the alpha-satellite
DNA on each arm is a pericentromeric re-
gion (diagonal lines), which is usually
comprised of a complex arrangement of
segmental duplications and is polymorphic
in size. The junction of the unique DNA
with this pericentromeric zone was identi-
fied for each chromosome arm, and a 1 Mb
contig of BAC clones was developed (solid
black line). The dotted black lines repre-
sent clones spaced every 500 kb up to
a minimum of 5 Mb for each unique chro-
mosome arm. Euchromatin refers to the
unique DNA and the pericentromeric re-
peats of each chromosome arm, in contrast
to heterochromatin, which is comprised of
highly repeated satellite DNAs, including
alpha-satellite arrays.
(B) A representative metaphase from case 6 shows positive hybridization to a centromere alpha-satellite probe (aqua) on the two normal
chromosome 2 homologs and the SMC (arrow). The normal homologs also show positive hybridization for a 2p clone (green) and 2q clone
(red), but no hybridization is observed on the SMC. The 2p clone (RP11-349C16) is located 2.9 Mb from the centromere gap and the 2q
clone (RP11-708D7) is 0.3 Mb from the centromere gap.
(C) A representative metaphase from case 3 shows positive hybridization on both normal chromosome 1 homologs and the SMC (arrow) for
unique clones on 1p (red) and 1q (green). The 1p clone (RP11-22F13) is located 1.1 Mb from the heterochromatin gap on the short arm,
while the 1q clone (RP4-679C16) is located 1.5 Mb from the heterochromatin gap on the long arm.0.1% NP-40 at room temperature for 30 s, and stained with DAPI
for 3 min. Slides were mounted in VectaShield antifade solution
(Vector Laboratories, Burlingame, CA) and analyzed via digital im-
aging with a CCD camera and software (SmartCapture 2, Digital
Scientiﬁc, Cambridge, UK).
Patient Samples
Informed consent was obtained from participants according to
a protocol approved by the Institutional Review Board at Emory
University. Once a patient was entered into the research study,
blood or amniocytes were sent to the Emory Genetics Laboratory
for culture for FISH analysis and for DNA isolation.
Samples from26patientswithnonsatellited SMCswere recruited
from several clinical diagnostic laboratories (cases of satellited
marker chromosomes were excluded). Of these, eight cases were
ascertained prenatally and 18 cases were ascertained postnatally.
Case 23 contained two SMCs that were derived from two different
chromosomes; therefore, these SMCswere counted separately. The
clinical indications for cytogenetic analysis and salient clinical
features are listed in Table S2. Case 11 has been reported separately
in more detail.37
Array CGH
Twomicroarray designswere utilized for these experiments: a com-
mercially available array (Agilent Human Genome CGH Microar-
ray Kit 44b) and a custom designed 4x44k CGH array.38 In the cus-
tom array design, the most proximal unique BAC clone for each400 The American Journal of Human Genetics 82, 398–410, Februarcentromere regionwas representedwith approximately tenprobes,
which then transitioned into the whole genome backbone cover-
age of one probe every 75 kb.
The experimental procedures followed the manufacturer’s rec-
ommended protocol (Agilent Technologies, Santa Clara, CA). In
brief, genomic DNA (1–3 mg) was digested with AluI and RsaI
(Promega, Madison, WI) for 2 hr. The DNA was labeled for 2 hr
with randomprimers, Cy-3- and Cy-5-dUTP dyes, and Exo-Klenow
fragment (Agilent Technologies, Santa Clara, CA). Patient DNA (la-
beledwithCy-3)was combinedwith a normal control DNA sample
(labeled with Cy-5) of the opposite sex (Promega, Madison, WI)
and hybridized to the array in the presence of Cot-1 DNA (Invitro-
gen, Carlsbad, CA). After a 24 hr hybridization at 65C, the slides
were washed and scanned with the GenePix Autoloader 4200AL
(Molecular Devices, Sunnyvale, CA).
Array Analysis and FISH Conﬁrmation
BlueFuse software (BlueGnome, Cambridge, UK) was utilized for
the examination of the data. Normalization of the data was per-
formedwith Block Lowess, which corrects for intensity-related var-
iation within images. Regions of copy-number alterations were
detected with set thresholds for the channel ratios based on two
or three standard deviations from the median of the autosomes.
Channel 1 (Ch1) represented the patient sample and channel
2 (Ch2) represented the normal control DNA. The thresholds for
the log2 ratios were set at 0.26 for ampliﬁcations and 0.32 for
deletions. In order for the software to call an abnormality, they 2008
Table 1. Proximal, Intermediate, and Distal FISH-Tested Centromere Clones
Chr Proximal Clone Distance from Gap (Mb) Intermediate Clone Distance from Gap (Mb) Distal Clone Distance from Gap (Mb)
1p RP11-22F13 1.1 RP11-39H13 3.5 RP11-350E19 5.9
1q RP4-679C16 1.5 RP11-314N2 3.1 RP11-126K1 6.7
2p RP11-349C16 2.9 RP11-269K22 4.9 RP11-147C20 7.4
2q RP11-708D7 0.3 RP11-173M4 3.0 RP11-609J13 5.0
3p RP11-714D16 0.3 RP11-695J20 1.4 RP11-14B7 5.0
3q RP13-503K1 0.2 RP11-8N23 2.3 RP11-319J24 4.9
4p RP11-317G22 0.6 RP11-381K8 3.1 RP11-542I3 5.3
4q RP11-365H22 0 RP11-231C18 2.5 RP11-533F5 4.9
5p CTC-339C6 0.5 CTD-2282F8 3.0 CTD-2005E22 5.0
5q CTD-2276O24 0.6 RP11-94D20 3.1 RP11-175M2 5.6
6p RP11-513F12 2.1 RP11-360D14 3.6 RP3-357H1 6.9
6q RP11-396K16 0.4 RP11-59D5 2.5 RP11-24C14 5.5
7p RP11-792I5 2.5 RP11-636L15 3.8 RP11-95E2 7.4
7q RP11-144H20 0.5 RP11-416N13 2.7 RP13-936H15 5.4
8p RP11-643N23 0.2 RP11-465K16 3.0 RP11-479P21 4.7
8q RP11-1134I14 1.1 RP11-22C8 3.0 RP11-759A9 4.4
9p RP11-113O24 7.6 RP11-297B17 9.0 RP11-366F19 12.7
9q RP11-274B18 4.3 RP11-366I5 7.0 RP11-404E6 9.1
10p RP11-365P10 2.3 RP11-382K22 3.0 RP11-479G22 5.8
10q RP11-351D16 1.1 RP11-67C2 3.5 RP11-463P17 6.2
11p RP11-709C9 3.2 CTD-2532J14 4.9 RP11-513I7 7.9
11q RP11-131J4 0.4 RP11-659P15 2.9 RP11-736I10 5.0
12p RP11-1035D8 0.8 RP11-414A12 3.3 RP11-1110J8 5.1
12q RP11-804F13 1.0 RP11-242C24 2.0 RP11-328C8 4.9
13q RP11-61K9 1.4 RP11-569O4 2.5 RP11-165I9 6.6
14q CTD-2292M16 1.6 RP11-903H12 2.0 RP11-66N24 5.0
15q RP11-289D12 2.1 RP11-73C9 3.1 RP13-911E13 6.3
16p RP11-43P5 0.1 RP11-1378C7 2.0 RP11-297C4 4.7
16q RP11-46D6 0.1 RP11-189E14 3.0 RP11-397C9 5.0
17p RP11-64J19 1.0 RP11-28B23 3.3 RP11-367G9 5.2
17q RP11-173M1 0.3 RP11-1148O4 3.0 RP11-640N20 5.0
18p RP11-681N23 1.4 RP11-78A19 3.5 RP11-243E13 5.0
18q RP11-254G11 0.1 RP11-403A21 3.0 RP11-203G13 5.0
19p RP11-771C12 0.2 CTB-135N1 2.3 CTC-251H24 6.0
19q CTC-452L11 0.1 CTC-525D6 2.2 CTC-442E9 4.5
20p RP4-694B14 0.6 RP11-526K17 1.7 RP5-1049G11 5.6
20q RP5-1018D12 1.3 RP11-60H7 2.9 RP5-977B1 6.5
21q RP11-625C23 1.2 RP11-1L19 3.5 RP1-238P10 5.5
22q RP11-419G2 1.4 RP11-488D20 3.4 RP11-432M13 6.6
Xp RP3-344I7 0.5 RP11-382E3 3.2 RP1-290F12 5.5
Xq RP1-267M5 0.4 RP11-262B12 2.6 RP11-747I9 3.9
Yp RP11-375P13 2.6 - - RP11-115H13 4.4
Yq RP11-350I10 0.9 RP11-283B24 3.5 RP11-442J5 4.6
The proximal and intermediate clones mapped uniquely, whereas three of the distal clones displayed crosshybridization. All 540 FISH-mapped clones are
listed in the Supplemental Data.minimum number of probes included in a region of deletion or
ampliﬁcation was set to ﬁve oligonucleotides.38
For conﬁrmation of the array results, FISH analyses were per-
formed with the centromere clone panel. For SMCs containing
unique DNA, at least three clones were tested: the most proximal
unique clones for each chromosome arm and themost distal clone
from the chromosome arm that contained unique DNA. For SMCs
that did not contain unique DNA, the most proximal unique
clones for each chromosome armwere tested. Other abnormalities
in addition to the SMC detected by aCGH (cases 8 and 12) were
also conﬁrmed by FISH.
Bioinformatics Resources
The UCSC genome browser (May 2004) was utilized for the assess-
ment of the genomic architecture of the SMCs (Segmental Duplica-The Amtions track) and for the assessment of the number of known genes
(UCSC Known Genes track) contained within the SMCs.36,39,40
The genes were displayed in four colors representing the level of
supporting data: black, entry in the Protein Databank (PDB);
dark blue, either a corresponding RefSeq messenger RNA (mRNA)
that is reviewed or validated or a corresponding Swiss-Prot protein;
medium blue, corresponding RefSeq mRNA that is not reviewed
nor validated; and light blue, no corresponding PDB entry, RefSeq
mRNA, or Swiss-Prot protein. For this study, the number of known
genes included the genes that have an entry in the PDB (black) or
a validated RefSeq mRNA or Swiss-Prot protein entry (dark blue).
Noncoding genes and splice variants were not included. In addi-
tion, genes with at least ﬁve family members were counted as
one gene family, such as the histone H2 family and the S100
protein family.erican Journal of Human Genetics 82, 398–410, February 2008 401
Results
Similar to our previous development of molecular-ruler
clones for all human telomeres,41 a molecular-ruler clone
panel for all humancentromereswasdeveloped (Figure 1A).
The most proximal unique BAC clone for each centromere
was identiﬁed, and a panel of clones was developed up to
approximately 5 Mb from the centromere or heterochro-
matin gap. Table 1 displays three FISH-mapped clones for
each chromosome arm. The centromere clone panel con-
tains 963 clones, including 756 clones in the unique
regions of the chromosome arms and 207 clones in the
pericentromeric regions.
Clone Validation
Approximately 50% (n ¼ 382) of the clones located in the
unique chromosomal arms were analyzed by FISH (Table
S1). From this subset, only 85% of the clones mapped
uniquely and to the correct location in the genome. The re-
maining 15% of the clones mapped incorrectly (7.6%) or
displayed crosshybridization to other sites (7.4%), despite
being predicted to be unique in the databases. This is
consistent with results from Ballif et al. that demonstrated
that approximately 2% of clones in the centromere regions
mapped incorrectly and approximately 22% of clones
displayed crosshybridization.28 Subtelomeric regions have
also been shown to be problematic in the mapping of the
human genome,33,42 and together, these results provide
a cautionary note regarding utilization of data and clones
from public genomic databases without independent ex-
perimental conﬁrmation of location and uniqueness.
Approximately 76% (n ¼ 158) of the clones located
within the pericentromeric repeat region were analyzed
by FISH (Table S1). As expected for regions containing sub-
stantial repeats and segmental duplications, only approxi-
mately 27% of clones showed a unique signal to the correct
location, whereas approximately 5%mapped to the wrong
location and approximately 68% displayed crosshybridiza-
tion to additional sites.
Determination of Unique DNA Content of SMCs
The centromere-speciﬁc molecular-ruler clone panel was
utilized for the characterization of SMCs obtained from
multiple cytogenetic laboratories. To determine whether
a SMC contained unique sequence DNA, we tested the
most proximal unique BAC clones from the molecular-
ruler clone set (see Table 1) on the samples. The location
of the clone is indicated according to the distance from
the centromere gap into the p or q arm.
The mapping results, unique DNA content, and gene
content of all 27 SMCs are shown in Table 2. The total eu-
chromatin column indicates the size of the SMC including
the pericentromeric repeat DNA and unique DNA, whereas
the total unique column shows only the amount of unique
DNA (as determined by the most proximal unique clone).
The marker chromosomes derived from nonacrocentrics402 The American Journal of Human Genetics 82, 398–410, Februarwere presumed to be rings, on the basis of their appearance
and mitotic instability. Seven of the markers (26%) did not
contain unique DNA and were thus comprised solely of
pericentromeric repeats and/or centromeric alpha-satellite
DNA. An example is shown for case 6 (Figure 1B), which
contained a SMC known to be derived from chromosome
2 from studies performed in the referring laboratory. The
most proximal unique clone on 2p (RP11-349C16) was
not present on the SMC, and the most proximal unique
clone on the long arm (RP11-708D7) was also negative. Be-
cause this SMC was detected prenatally, the determination
that it is unique negative and less likely to be associated
with an abnormal phenotype was valuable information
for genetic counseling.
The remaining 20 SMCs were unique positive and con-
tained varying amounts of unique DNA, ranging in size
from 0.3 Mb to 22.2 Mb (Table 2). Case 3 is an example
of a marker chromosome that contains unique material
derived from both the p and q arms of chromosome 1 (Fig-
ure 1C). The proband presented with developmental delay,
and the SMC was determined to be derived from chromo-
some 1 by the referring laboratory. In this case, the most
proximal unique clones on 1p (RP11-22F13) and on 1q
(RP4-679C16) were both positive on the SMC (Figure 1C).
These results indicated that the SMC contained uniquema-
terial derived from both chromosome arms, and further
FISH mapping was necessary for the delineation of the
breakpoints of the SMC (Table 2; data not shown).
The average amount of unique DNA for these 20 SMCs
was approximately 6.5 Mb, with an average of approxi-
mately 33 known genes. The average size of the total
euchromatic DNA content, including the pericentromeric
repeats, was approximately 7.6 Mb. Half of these 20 SMCs
contained less than 5 Mb of unique DNA, ﬁve SMCs
contained 5–10 Mb of unique DNA, and the remaining
ﬁve SMCs contained greater than 10 Mb of unique DNA.
Identiﬁcation of a Cryptic Deletion Associated
with a Small Ring Chromosome Formed
by the ‘‘McClintock Mechanism’’
One of our cases (case 7) involved amosaic familial r(4) that
was ascertained prenatally in another laboratory. The
mother, who is intellectually normal but has unilateral
ear anomalies andminor visual deﬁciencies, was also found
to carry the r(4) in approximately 66% of her peripheral
lymphocytes. The parents were counseled that the marker
chromosome in the fetus and mother appeared to be iden-
tical, and the pregnancy was continued. At 3 years of age,
the proband was referred to a genetics clinic for mild
speech delay. Re-analysis of the proband’s chromosomes
conﬁrmed the presence of the r(4) and showed two normal
chromosome 4 homologs with positive hybridization
for unique BAC clones on the p arm and q arm, located
1.08 Mb and 0.55 Mb from the centromere gap, respec-
tively (Figure 2A). The ring chromosome was positive for
the p arm clone but negative for the q arm clone, indicating
the presence of uniqueDNA from the short arm but not they 2008






















1 1 Prenatal 13.7 0 13.7 14.8 >50 de novo 57% Not tested
2 1 Postnatal >13.9 0 >13.9 >15 >50 de novo 25% Not tested
3 1 Postnatal 0.2 11.4–15 11.6–15.2 14.2–17.8 >50 de novo 10% Custom; Not detected:
Mosaic
4 1 Postnatal 0e 0 0 0.1 0–5 de novo 66% Custom; Not detected:
No unique
5 2 Postnatal 0e 8.5 8.5 9.5 11–50 de novo 41% þ1; 50% þ2 44b; Detected
6 2 Prenatal 0e 0 0 0.2 0–5 de novo 100% Not tested
7 4 Prenatal 4.4 0 4.4 5.0 11–50 Mat 33% 44b; Detected
8 4 Postnatal 4.2 18.0 22.2 22.8 11–50 Pat 60% Custom; Detectedd
9 5 Postnatal 0 10.9–12.6 10.9–12.6 11.5–13.2 11–50 de novo 25% Not tested
10 5 Prenatal 1.1 1 2.1* 3.2 0–5 de novo 88% þ2; 12% þ1 Not tested
11 8 Postnatal 3.1 0.8 3.9 5.2 11–50 de novo 96% 44b; Detected
12 8 Postnatal 4.5 2.2 6.7 8 11–50 de novo 45% þ1; 45% þ2 44b; Detectedd
13 11 Postnatal 0.2 2.3 2.5 6.1 11–50 de novo 14% 44b; Not detected: Mosaic
14 13 Prenatal N/A 8.6–13.5 8.6–13.5 10–14.9 11–50 de novo 100% Not tested
15 15 Postnatal N/A 0e 0 0.3 0–5 de novo 70% Not tested
16 16 Postnatal 0.7 0 0.7 0.8 0–5 de novo 85% 44b; Detected
17 17 Prenatal 7.3 0 7.3 8.3 >50 de novo 60% 44b; Detected
18 18 Postnatal 0e 0 0 1 0–5 Pat 80% Custom; Not detected:
No unique
19 18 Prenatal 1.2 0 1.2 2.6 6–10 de novo 100% Not tested
20 19 Postnatal 0 0.3 0.3 0.4 0–5 de novo 100% Custom; Detected
21 20 Postnatal 6.6 0e 6.6 8.5 11–50 Mat 68% 44b; Detected
22 20 Postnatal 0e 0.3 0.3 1.9 6–10 de novo 75% Custom; Detected
23a 20 Prenatal 0 0 0 0 0–5 de novo 6% Custom; Not detected:
Mosaic and No unique
23b 14/22 Prenatal N/A 0 0 0 0–5 de novo 6% Custom; Not detected:
Mosaic and No unique
24 21 Postnatal N/A 0.4 0.4 1.6 6–10 de novo 50% Not tested
25 21 Postnatal N/A 4.7 4.7 5.9 11–50 Unk 75% 44b; Detected
26 13/21 Postnatal N/A 0 0 0 0–5 de novo 24% Not tested
* indicates that case 10 contains two SMCs: one that contains only p arm DNA and a second that contains only q arm DNA. N/A indicates that the p arms of
the acrocentric chromosomes were not tested.
a Total unique DNA indicates the amount of unique DNA sequences present on the SMC.
b Total euchromatin indicates the amount of pericentromeric and unique DNA sequences present on the SMC.
c See Material and Methods for definition of known genes. Genes are grouped as: 0–5, 6–10, 11–50, and > 50.
d aCGH results detected an additional abnormality.
e SMC contains pericentromeric DNA (but no unique DNA) for this chromosome arm.long arm of chromosome 4. The proband has an approxi-
mately 4.4 Mb partial trisomy of unique DNA (approxi-
mately 5 Mb including the pericentromeric repeats) in
about 33% of her peripheral lymphocytes. This proximal re-
gion of chromosome 4p includes approximately 16 known
genes.
FISH studies of the mother showed the same pattern of
positive hybridization for unique BAC clones from 4p on
her ring chromosome and a small positive signal for the
chromosome 4 alpha-satellite probe (Figure 2B). However,
unlike the proband, the mother had only one normal
chromosome 4 homolog with positive hybridization to
the 4p unique clones and centromeric alpha-satellite
probe. The second chromosome 4 homolog showed no
hybridization to the 4p unique clones and had a slightly
reduced intensity of the alpha-satellite signal, and there-The Amfore was deleted for approximately 4.4 Mb of unique
DNA from proximal 4p. This result indicates that the
mother is a balanced carrier for a cryptic pericentromeric
deletion and a complementary ring chromosome, as de-
picted in Figure 2C. Because the r(4) in present in only ap-
proximately 66% of the mother’s peripheral lymphocytes,
she is monosmic for 4p in 33% of cells in this tissue. The
level of mosaicism might vary substantially in other tis-
sues, and given her normal intelligence, one would predict
a higher percentage of balanced cells might be present in
the brain.
Mechanism of Formation of SMCs
Seventeennonacrocentric SMCs containedunique sequence
DNA from at least one chromosome arm. To assess mecha-
nism of formation, we excluded the subset of cases thaterican Journal of Human Genetics 82, 398–410, February 2008 403
Figure 2. FISH Analysis of the ring(4) in Case 7
(A) FISH analysis with unique pericentromeric BAC clones for chromosome 4. The proband shows two normal chromosome 4 homologs
with positive hybridization for a p arm-specific probe RP11-191J2 (green) and a q arm-specific probe RP11-724F22 (red), located
1.1 Mb and 0.6 Mb from the centromere, respectively. On the supernumerary ring chromosome, only the p arm probe shows positive
hybridization, excluding the presence of unique DNA from the q arm in ring formation.
(B) The mother of case 7 showed the same pattern of positive hybridization for unique BAC clones from 4p on her ring marker (red signal
corresponding to clone RP11-500G9 at 5.02 Mb from the centromere gap) and a small positive signal for the chromosome 4 alpha-satellite
probe (green). The mother shows one normal chromosome 4 homolog with positive hybridization to 4p unique clones and centromeric
alpha satellite, but also a deleted chromosome 4 homolog negative for 4p unique clones and a slightly reduced intensity alpha-satellite
signal.
(C) Model of small-ring-chromosome formation by centromere misdivision is shown. One chromosomal break occurs within the centro-
meric alpha satellite array, and a second break occurs in either the p or q arm of the chromosome. This mechanism produces two functional
centromeres and two viable chromosome products. The resulting balanced carrier state comprises a deleted chromosome and a com-
plementary ring chromosome. This schematic figure is virtually identical to that drawn by B. McClintock in 1938 on the basis of her
observations in maize.61contained only pericentromeric repeats for one chromo-
some arm (cases 5, 21, and 22).Of the remaining 14 fully in-
formative cases, ﬁve SMCs (36%) contained unique se-
quence DNA derived from both the p and q arms of the
chromosome, consistent with Model I (see Introduction).
Nine cases (64%) contained unique DNA derived from
either the p or q arm of the chromosome and are consistent
withModel II. Other recent studies15,16,28 have assessed the
unique DNA content of marker chromosomes by using
FISH, providingdata onwhether the SMCs containDNAde-
rived from one or both chromosome arms. Combining our
14 cases with these studies, 41 of 50 cases (82%) of ring
marker chromosomes are consistent with a mechanism of
centromere misdivision (Model II).
Comprehensive Analysis of SMCs via aCGH
After the development of a custom oligonucleotide array
containing centromere molecular ruler coverage, aCGH
was determined to be the most efﬁcient method for the
rapid determination of the DNA content of SMCs. Targeted
FISH analysis can then be performed for the conﬁrmation
of the aCGH results and for the studying of parents or ad-
ditional family members. Several additional cases illustrate
the varying amounts of unique DNA present in SMCs and
the precision of aCGH in identifying breakpoints and
determining unique DNA and gene content. Case 21 is
a mosaic (68%) SMC derived from chromosome 20 (Fig-
ure 3A). A gain of approximately 7 Mb in the region of
the p arm was observed, indicating that the SMC contains404 The American Journal of Human Genetics 82, 398–410, Februarunique DNA from the p arm of chromosome 20 but not the
q arm. FISH analysis with the molecular-ruler clone panel
veriﬁed these array results.
Case 22 is a small, mosaic SMC derived from chromo-
some 20. A gain of approximately 0.3 Mb of unique DNA
in the region of the q arm of chromosome 20 can be
seen by aCGH (Figure 3B). FISH results with the unique
BAC clones in the centromeric region of chromosome
20 conﬁrmed the aCGH data (data not shown).
As shown in Table 2, the chromosome origin and size of
the SMC were determined by aCGH for 11 cases. These re-
sults were consistent with FISH analyses in all cases, with
breakpoints within 1 Mb. The breakpoints determined by
aCGH were more precise than those determined by FISH,
because the average probe spacing was at least 75 kb in
the microarray studies. Six SMCs were undetectable by
aCGH (Table 2) because of low-level mosaicism of the
SMCs (<15%) (cases 3, 13, 23a, and 23b) or no unique
DNA was present on the SMCs as determined by FISH
(cases 4, 18, 23a, and 23b).
The combination of FISH along with a microarray con-
taining genome-wide coverage, rather than a pericentro-
mere-targeted array, is advantageous in the characterization
of marker chromosomes. Microarray data revealed addi-
tional abnormalities in two cases (cases 8 and 12). For case
8, a paternally inherited SMC derived from chromosome
4 was detected by aCGH and conﬁrmed by FISH.
The aCGH results also revealed an approximately 5.7 Mb
interstitial deletion of chromosome 6. This deletion aty 2008
6q22.31–q22.32 was conﬁrmed by FISH and was deter-
mined to be inherited from the proband’s mother (data
not shown). A recent paper reported a larger deletion of
this region (9.9–11.6 Mb in q22.31q23.1) in a phenotypi-
cally normal individual.43
The results of case 12 which contains two de novo SMCs
derived from chromosome 8 are shown in Figure 4. Themo-
saic markers (45% þ2mar, 45% þmar) were ascertained in
a proband with learning disabilities and obesity. The
aCGH results reveal a gain of approximately 4 Mb of the p
arm and approximately 3Mbof the q armmaterial adjacent
to the centromere gap of chromosome 8 (Figure 4A). FISH-
mapping studies using the molecular-ruler clones con-
ﬁrmed the array results. In addition, FISH studies demon-
strated that the second marker chromosome contained
only approximately 0.5 Mb of DNA from the p arm and
approximately 3 Mb of euchromatic DNA from the q arm
(data not shown). The array results also identiﬁed an addi-
tional gain of approximately 3.8 Mb in the 8p22 region
(Figure 4A). This result alone cannot determine whether
the gain was the result of a complex rearrangement in the
SMC or an additional duplication of 8p22 elsewhere in the
genome. BAC clones speciﬁc to the ampliﬁed region of
8p22 (RP11-10C8 and RP11-433L7) were utilized in FISH as-
says for conﬁrmation that the additional material was con-
tained within the larger marker chromosome. Both clones
were present on the marker chromosome, conﬁrming that
a complex rearrangement involving this region occurred
in the formation of the SMC (Figure 4B). In this case, the
combination of genome-wide aCGH and FISH technologies
Figure 3. Array CGH Analysis of Two SMCs Containing Unique
DNA from Only One Chromosome Arm
The x axis displays the log2 ratios of the patient sample (Ch1)
versus a normal control sample (Ch2).
(A) Array CGH analysis with a commercial oligonucleotide array
(Agilent 44b) showed a gain of copy number on chromosome 20
for case 21. A group of probes in the p arm adjacent to the centro-
mere gap exceeds the threshold for duplication.
(B) Array CGH analysis with a custom oligonucleotide array showed
a gain of probes on chromosome 20 for case 22. A group of probes
in the q arm of chromosome 20 exceeds the threshold for duplica-
tion.The Amallowed for an accurate assessment of the size and chromo-
somal origin of the DNA contained within the two SMCs.
Discussion
Despite the signiﬁcance of centromeres in the stability and
segregation of human chromosomes, these regions remain
a challenge to the ﬁnal completion of mapping and se-
quencing the human genome.33,44 The main obstacle is
the correct assembly of the DNA sequences because these
regions contain complex repetitive sequences in the transi-
tion zone from centromeric alpha-satellite DNA into the
pericentromeric repeat regions and unique chromosome-
speciﬁc sequences.36,45,46
In this study, targeted analysis of all 43 human pericen-
tromeric regions was performed for the identiﬁcation of
the junction of the unique DNA with the pericentromeric
repeats. The most proximal unique BAC clone for each
chromosome arm was identiﬁed and validated by FISH
assays, and ‘‘molecular rulers’’ of validated BAC clones
from the centromere gap to approximately 5 Mb of each
chromosome arm were developed (see Table 1 and Table
S1). Recently, Ballif and colleagues developed a panel of
974 FISH-mapped clones covering approximately 5 Mb of
the unique centromere regions and utilized these clones
on a BAC-basedmicroarray.28 Although the clone selection
for the most proximal unique clones varied for several
chromosome arms, the independent analysis by both
groups yielded similar average distances of the most prox-
imal clone to the centromere gap (1.2 Mb in this study and
1.6 Mb in Ballif et al.28).
Figure 4. Array CGH and FISH Results of a SMC with a Complex
Rearrangement—Case 12
(A) Array CGH analysis with a commercial oligonucleotide array
(Agilent 44b) shows the gain of probes on the p and q arms
adjacent to the centromere gap of chromosome 8, as well as an
additional gain much more distally at 8p22.
(B) A duplication of 8p22 was confirmed by FISH analysis with
unique BAC clones from 8p22 (red; RP11-10C8, green; RP11-
433L7), which showed positive hybridization to the marker chro-
mosome (arrow).erican Journal of Human Genetics 82, 398–410, February 2008 405
Identiﬁcation of Unique-Negative versus
Unique-Positive SMCs
Improved physical maps of each human chromosome and
the development of BAC clones precisely mapped in each
centromeric region now allows molecular characterization
of SMCs in a research or clinical setting by FISH or aCGH.
Of particular clinical importance might be the ability to
rapidly distinguish unique sequence-negative from unique
sequence-positive SMCs, because the former are less likely
to be associated with abnormal outcomes if identiﬁed
prenatally.
Approximately 26% (7 of 27) of the SMCs in our study
were unique negative. One of these (case 23) provides an ex-
ample of prenatal ascertainment, in which the fetus was
found to have two SMCs derived from different chromo-
somes. Our analysis showed no unique DNA present on ei-
ther of these two SMCs. At 9 months of age, the patient is
healthywithnormal developmentalmilestones. Larger, pro-
spective studies are needed to conﬁrm the predicted low risk
associated with unique-negative SMCs, but certainly this
precise determination of DNA content should be more pre-
dictive than empiric data based simply on morphology
(e.g., satellited versus nonsatellited) or banding characteris-
tics (e.g., presence or absence of C band-negative material).
Of the 27 SMCs reported here, approximately 74% (20 of
27) were unique-positive SMCs, containing an average of
approximately 6.5Mbunique sequence and approximately
33 known genes. These represent signiﬁcant partial triso-
mies and are more likely to be causative of abnormal clini-
cal features. Two of our three most severely affected cases
(cases 3 and 14) were found to have marker chromosomes
that contained at least 8.6 Mb and 11.6 Mb of unique DNA
sequences, consistent with the notion that larger marker
chromosomes are more likely to be associated with a severe
phenotype.
Although the small number of cases in this study is not
sufﬁcient to contribute to chromosome-speciﬁc SMC geno-
type-phenotype correlations, an international database of
SMCs with clinical descriptions has been established (see
Web Resources below).3 The current molecular cytogenetic
techniques that allow for detailed molecular data on the
gene content and size of SMCs will signiﬁcantly improve
on such correlations in the future. As more information
is obtained on the size and gene content among markers
derived from the same chromosome, risk estimates might
be reﬁned. In addition to the chromosome origin and
unique DNA content, the level of mosaicism might also
alter the risk associated with an abnormal phenotype. A
recent study of 137 marker cases demonstrated that 41%
were mosaic, whereas the remaining SMCs were present
in every cell.2 For mosaic SMCs, the levels of mosaicism
have been shown to vary among different tissues.47 Taking
all of these factors into consideration, including the levels
of mosaicism, unique DNA, and gene content of SMCs,
we would expect that the ability to predict the clinical
signiﬁcance in a prenatal setting and the determination
of prognosis in a young child will be greatly improved.406 The American Journal of Human Genetics 82, 398–410, FebruarRediscovery of the McClintock Mechanism
of Small-Ring Formation and Implications
for Genetic Counseling
The relative frequency of two major mechanisms of small-
ring-chromosome formation was assessed in this study and
demonstrated that more than half of the SMCs are consis-
tent with a mechanism of centromere misdivision (Model
II). One of these cases (case 7) involved a patient with a
maternally inherited mosaic small r(4) initially identiﬁed
prenatally. Analysis of the mother’s chromosomes revealed
a cryptic deletion present in one of her chromosome 4 ho-
mologs, creating a mosaic balanced carrier state for a del(4)
and complementary r(4).
At least 11 additional cases of deletion associated with a
complementary ring chromosome have been reported in
the literature.31,48–57 These cases all involved visible dele-
tions inonehomolog,whereas case7 in this study is theﬁrst
reported cryptic deletion associatedwith ring-chromosome
formation. Three of the previously reported cases31,55,57
involve the more rare class of marker chromosomes that
do not contain detectable alpha-satellite sequences and
are referred to as neocentric markers.58,59
Identiﬁcation of such cryptic balanced carriers is obvi-
ously essential for accurate genetic counseling about recur-
rence risks, as carriers are at high risk for two different
unbalanced offspring by transmission of only the deleted
homolog or the ring chromosome along with a normal
homolog. Examples of both of these transmissions have
been reported in the literature,48,51–53,56,57,60 and in at least
one family, both unbalanced products were identiﬁed in
affected children with different phenotypes.51
This mechanism of breakage within the centromere
creating a pericentromeric deletion and complementary
ring chromosome was ﬁrst described in 1938 by B. McClin-
tock61 in one of her classic papers on maize cytogenetics.
In this work, she noted that ‘‘the size of the ring-shaped
chromosome and the extent of the deﬁciency in the rod-
chromosome were comparable.’’ She also noted that ‘‘the
deﬁcient rod and its compensating ring chromosome arose
as the result of two breaks in the normal chromosome V,
one break passing through the spindle ﬁber attachment
region,’’ referring to the centromere of the chromosome.
Because this description matches perfectly with the model
here being suggested as the major mechanism for human
ring marker formation, we propose that this mechanism
be referred to as the McClintock mechanism.
It is currently standard practice in clinical laboratories
for cytogeneticists to identify the chromosome of origin
of a marker chromosome by using probes only from the
centromeric alpha-satellite regions. By this approach,
only cytogenetically visible deletions in the surrounding
euchromatic DNA have previously been noted. It is not
uncommon for them to identify a small marker chromo-
some in a child with developmental delay and/or mental
retardation but then ﬁnd the same marker in a normal
parent and perhaps other normal family members. In
this situation, the marker chromosome in the proband isy 2008
usually considered coincidental to her/his delay or abnor-
mal phenotype. This approach should now be considered
insufﬁcient, given the possibility of cryptic pericentro-
meric deletions and a balanced del and ring state in a nor-
mal parent and other relatives. It is imperative to perform
molecular cytogenetic investigations to rule out a cryptic
pericentromeric deletion producing a balanced del and
ring carrier state in the parent carrying a marker chromo-
some. These follow-up studies are best performed by FISH
for the detection of the cryptic deletion because aCGH
and other quantitative molecular methods could demon-
strate apparently normal dosage results.
Comprehensive SMC Analysis by aCGH and FISH
Different aCGH platforms, using either BAC clones or oli-
gonucleotides, have become readily available for the detec-
tion of copy-number imbalances, and several studies have
recently used this technology to characterize SMCs.28,62–66
High-resolution genome-wide analysis of SMCs via aCGH
has proven to be advantageous in the detection of complex
rearrangements that might result in the formation of
a marker chromosome. The genome-wide coverage of the
custom oligonucleotide array, with enhanced probe den-
sity in the unique pericentromere regions, provides the
opportunity for us to determine the size and precise con-
tent of SMCs in one assay. Even with the development of
the pericentromeric molecular ruler clones covering up to
5 Mb of unique DNA, additional clones had to be selected
for the completion of the FISH-mapping studies of nearly
35% of the cases presented in this paper. It has recently
been suggested that a pericentromeric BAC-based microar-
ray including coverage of the most proximal unique 10Mb
of DNA would be valuable in the sizing of SMCs28 so that
these larger marker chromosomes could be accurately
sized. Our data suggest that the coverage would need to
extend to at least 15 Mb as approximately 19% of the
SMCs in this study contained at least 10 Mb of unique
DNA derived from a single chromosome arm. Furthermore,
the complex rearrangement of the 8p22 region involved in
the SMC (case 12) would not have been detected with
typical FISH-mapping studies or a targeted pericentromeric
array. These results support the use of a genome-wide
microarray in the characterization of SMCs. Such a micro-
array allows for the sizing and characterization of SMCs in
an efﬁcient manner, as well as the identiﬁcation of other
potential imbalances elsewhere in the genome.
Our studies also demonstrate that FISH analysis is often
required in conjunction with aCGH studies. In this study,
four SMCs (cases 3, 13, 23a, and 23b) were undetectable by
aCGH because of a low level of mosaicism. As determined
by metaphase FISH analysis, the SMCs were present in less
than 14% of the cells. However, we easily detected another
marker chromosome that was present in only 33% of the
cells (case 7), suggesting that minimum detection range
is between 14%–33%. This range is similar to a previous
report where a mosaic trisomy 21 sample was easily de-
tected by aCGH when present in only 20% of cells, butThe Amnot in 10% of cells.64 In addition, some SMCs might not
appear as a gain by aCGH because of a lack of unique
DNA content. In this study, four marker chromosomes
did not contain unique DNA, as determined by aCGH
and FISH studies (cases 4, 18, 23a, and 23b). For these
samples, FISH was required for the identiﬁcation of the
chromosomal origin of the SMC with alpha-satellite and
pericentromeric-repeat-containing probes.
Tremendous progress has been made since the landmark
study by Warburton in 1991 describing the empiric risk
ﬁgures for small supernumerary marker chromosomes de-
tected prenatally.10 Analysis by aCGH and FISH is now fea-
sible on a timely clinical basis and can accurately determine
the size and gene content of such markers. The develop-
ment of genotype-phenotype databases for the determina-
tion of clinical signiﬁcance and prognosis will be extremely
useful for prenatal and pediatric settings.
Supplemental Data
Two tables are available at http://www.ajhg.org/.
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